loadpatents
name:-0.01157808303833
name:-0.0064959526062012
name:-0.00051093101501465
Darland; Gary Patent Filings

Darland; Gary

Patent Applications and Registrations

Patent applications and USPTO patent grants for Darland; Gary.The latest application filed is for "cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentan- oyl)cyclopent-2-en-1-one derivatives, substantially enantiomerically pure compositions and methods".

Company Profile
0.8.9
  • Darland; Gary - Port Orchard WA
  • Darland; Gary - Gig Harbor WA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentan- oyl) cyclopent-2-en-1-one derivatives, substantially enantiomerically pure compositions and methods
Grant 8,829,056 - Carroll , et al. September 9, 2
2014-09-09
Cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentan- Oyl)cyclopent-2-en-1-one Derivatives, Substantially Enantiomerically Pure Compositions And Methods
App 20130217781 - CARROLL; Brian J. ;   et al.
2013-08-22
Compositions that treat or inhibit pathological conditions associated with inflammatory response
Grant 8,486,457 - Tripp , et al. July 16, 2
2013-07-16
Cis, 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpenta- noyl)cyclopent-2-en-1-derivatives, substantially enantiomerically pure compositions and methods
Grant 8,410,179 - Carroll , et al. April 2, 2
2013-04-02
CIS 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentan- oyl)cyclopent-2-en-1-derivatives, substantially enantiomerically pure compositions and methods
Grant 8,410,178 - Carroll , et al. April 2, 2
2013-04-02
Cis, 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpenta- Noyl)cyclopent-2-en-1-one Derivatives, Substantially Enantiomerically Pure Compositions And Methods
App 20130018105 - CARROLL; Brian J. ;   et al.
2013-01-17
Cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentan- Oyl)cyclopent-2-en-1-one Derivatives, Substantially Enantiomerically Pure Compositions And Methods
App 20120108671 - Carroll; Brian J. ;   et al.
2012-05-03
Tetrahydro-isoalpha Acid Compositions And Methods For Weight Management
App 20110136917 - Tripp; Matthew L. ;   et al.
2011-06-09
Dihydro-isoalpha Acid And Acacia Nilotica Extract Based Compositions And Methods For Weight Management
App 20110135768 - Darland; Gary ;   et al.
2011-06-09
Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
Grant 7,811,610 - Babish , et al. October 12, 2
2010-10-12
Substituted 1,3-cyclopentadione Multi-target Protein Kinase Modulators Of Cancer, Angiogenesis And The Inflammatory Pathways Associated Therewith
App 20100137449 - Tripp; Matthew L. ;   et al.
2010-06-03
Anti-Inflammatory Pharmaceutical Compositions For Reducing Inflammation And The Treatment Or Prevention Of Gastric Toxicity
App 20070202208 - Babish; John ;   et al.
2007-08-30
Compositions that treat or inhibit pathological conditions associated with inflammatory response
App 20070160692 - Tripp; Matthew L. ;   et al.
2007-07-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed